Podczas EASD 2026SIBIONICS i PharmaSens badają nowe możliwości zautomatyzowanego dostarczania insuliny

ConferenceinsulinNeutral

AI Analysis

Summary

SiBionics and PharmaSens presented a new concept for automated insulin delivery at the EASD 2026 conference in Milan, combining continuous monitoring with future diabetes care approaches.

Importance:3/10

Sentiment:

0.00

diabetesinsulin deliverycontinuous monitoringautomated deliveryEASD 2026

Read the original article

Published by PR Newswire Biotech on October 5, 2026 9:56 AM

Read Original